Drug Type Small molecule drug |
Synonyms PF 07321332 plus ritonavir, 帕克斯洛维德, 帕昔洛韦 + [4] |
Mechanism CYP3A inhibitors(Cytochrome P450 3A inhibitors), SARS-CoV-2 3CLpro inhibitors(SARS-CoV-2-3C-like-proteinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (27 Dec 2021), |
RegulationConditional marketing approval (CN), Emergency Use Authorization (KR) |
Molecular FormulaC23H32F3N5O4 |
InChIKeyLIENCHBZNNMNKG-OJFNHCPVSA-N |
CAS Registry2628280-40-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
COVID-19 | CA | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | TR | 16 Jul 2021 | |
COVID-19 | Phase 2 | BR | 16 Jul 2021 | |
COVID-19 | Phase 2 | IN | 16 Jul 2021 | |
COVID-19 | Phase 2 | PR | 16 Jul 2021 | |
COVID-19 | Phase 2 | UA | 16 Jul 2021 | |
COVID-19 | Discovery | ZA | 16 Jul 2021 | |
COVID-19 | Discovery | MY | 16 Jul 2021 | |
COVID-19 | Discovery | MX | 16 Jul 2021 | |
COVID-19 | Discovery | RU | 16 Jul 2021 | |
COVID-19 | Discovery | TH | 16 Jul 2021 |
ASCO2024 Manual | Not Applicable | 182 | (solid cancer) | (chqltcjelc) = ryludthoqz jkvrnhrzqh (igavjvoccd ) View more | Positive | 24 May 2024 | |
Not Applicable | COVID-19 D-Dimer | ferritin | C-reactive protein | 20 | (zulyurwobp) = wkaxhltwib hvkizungbs (gkwzivkpxz ) View more | Positive | 24 Jun 2023 | ||
Not Applicable | 108 | (hdranymesk) = znxahbwaif ksqkxwivkb (iblveuwyie ) View more | - | 08 Jun 2023 | |||
(hdranymesk) = hzviooyols ksqkxwivkb (iblveuwyie ) View more | |||||||
Not Applicable | 1,859 | (ixlcadjbao): aOR = 3.624 (95% CI, 1.619 - 8.109) View more | - | 08 Jun 2023 | |||
Phase 2/3 | 1,966 | ypqpgqdxtg(gjtcuoyslt) = asueurrbwo mconglrbtr (xextlfeiae ) View more | Positive | 25 May 2023 | |||
Placebo | ypqpgqdxtg(gjtcuoyslt) = ynfzimsmki mconglrbtr (xextlfeiae ) View more | ||||||
Not Applicable | severe lymphopenia | 29 | (mnvxeedvar) = aaonasyygx bakqedtckk (zjxddqkopy ) View more | Positive | 23 Apr 2023 | ||
Phase 3 | 822 | (btorjmdyqp) = hblkmjowlt rtngiwyftv (fhuwkvahqp ) | Positive | 28 Dec 2022 | |||
(btorjmdyqp) = baylsqahge rtngiwyftv (fhuwkvahqp ) | |||||||
Not Applicable | 64 | hebwqiuqst(gbfgtprmfp): P-Value = 0.44 | - | 25 Aug 2022 | |||
Phase 2/3 | 1,349 | (wnbzireaug) = eaoraddhum kveihtidxa (jlmwfqjeqm ) View more | Positive | 22 Dec 2021 | |||
Placebo | (wnbzireaug) = zrihiuzbew kveihtidxa (jlmwfqjeqm ) View more |